2020 Meetings Abstracts: AACR Special Conference on Advancing Precision Medicine Drug Development: Incorporation of Real-World Data and Other Novel Strategies January 9–12, 2020; San Diego, CA ...
Abstract. Brain cancers are among the most lethal and challenging malignancies to treat in the clinic. An important impediment to effectively treat brain tumors is the blood–brain tumor barrier (BTB), ...
1McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Cancer Discov (2026) 16 (5): OF1.
Abstract:. In updated phase I clinical trial results, patients treated with zoldonrasib, a KRASG12D-selective inhibitor under study in non–small cell lung cancer, showed an objective response rate of ...
Search for other works by this author on: ...
1Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, ...
CCR7 overexpression enhances CAR-T–cell anti-lymphoma activity by directing therapeutic cells to lymph nodes and intrinsically strengthening their cytotoxic function, suggesting that accounting for ...
*Corresponding Author: Robert H. Vonderheide, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Boulevard, Philadelphia, PA 19104. E-mail: [email protected] ...
Defining the Antitumor Mechanism of Action of a Clinical-stage Compound as a Selective Degrader of the Nuclear Pore Complex Open Access Linjie Yuan; Wenzhi Ji; Brendan G. Dwyer; Joey Lu; Jing Bian; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results